Summary
ISQI Chart
Biotech Looks Ready To Run, But ETFs, Which One? IBB Vs. XBI
IBB and XBI are similar in many ways, but their relative past performance does not tell the story. IBB is more concentrated, and that is ultimately why I prefer it to XBI. Both ETFs target a similar objective, and are over-diversified. For reasons I explain here.
Is iShares Biotechnology ETF (IBB) a Strong ETF Right Now?
The iShares Biotechnology ETF (IBB) made its debut on 02/05/2001, and is a smart beta exchange traded fund that provides broad exposure to the Health Care ETFs category of the market.
Should You Invest in the iShares Biotechnology ETF (IBB)?
Launched on 02/05/2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.
iShares Biotechnology ETF Dividends
 IBB 3 months ago Paid | Quarterly | $0.12 Per Share |
| IBB 6 months ago Paid | Quarterly | $0.06 Per Share |
| IBB 9 months ago Paid | Quarterly | $0.2 Per Share |
| IBB 21 Mar 2024 Paid | Quarterly | $0.13 Per Share |
| IBB 20 Dec 2023 Paid | Quarterly | $0.12 Per Share |
iShares Biotechnology ETF Earnings
| IBB 3 months ago Paid | Quarterly | $0.12 Per Share |
| IBB 6 months ago Paid | Quarterly | $0.06 Per Share |
| IBB 9 months ago Paid | Quarterly | $0.2 Per Share |
| IBB 21 Mar 2024 Paid | Quarterly | $0.13 Per Share |
| IBB 20 Dec 2023 Paid | Quarterly | $0.12 Per Share |
iShares Biotechnology ETF (ISQI) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has iShares Biotechnology ETF ever had a stock split?
iShares Biotechnology ETF Profile
| XHAN Exchange | US Country |
Overview
The described company operates as an investment fund focused on tracking the performance of a specific underlying index. By investing at least 80% of its assets in the securities that comprise the index, the fund aims to mimic the index's returns and behavior closely. This strategy indicates a focus on providing investors with exposure to the components of a particular market or sector through the index it follows. However, it is noteworthy that the fund is characterized as non-diverse, which means it may concentrate its investments in a particular sector, company, or geographical area, potentially increasing the risk of volatility and loss due to lack of diversification.
Products and Services
The fund offers a targeted investment product that primarily focuses on securities from its underlying index, alongside additional financial instruments to potentially enhance returns and manage risks:
- Component Securities Investments: The core of the fund's portfolio comprises at least 80% investment in the securities that are part of the underlying index it tracks. This approach is designed to replicate the performance of the index, offering investors exposure to its specified market or sector.
- Futures, Options, and Swap Contracts: Up to 20% of the fund's assets may be allocated to futures, options, and swap contracts. These derivative financial instruments can serve multiple purposes, including hedging against market volatility, leveraging to amplify returns, and speculative investment opportunities, allowing the fund to potentially enhance its overall performance.
- Cash and Cash Equivalents: A portion of the fund's assets may be held in cash or cash equivalents. This allocation is strategic, enabling the fund to manage liquidity effectively, meet redemption requests promptly, and take advantage of new investment opportunities as they arise. Holding cash and cash equivalents can also provide a buffer against market downturns.
Contact Information
